Two-year randomized, placebo-controlled study of black currant anthocyanins on visual field in glaucoma

Ophthalmologica

Volumn 228, Issue 1, 2012, Pages 26-35

  Ohguro, Hiroshi ^a   Ohguro, Ikuyo ^a   Katai, Maki ^a   Tanaka, Sachie ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Black currant anthocyanins; Glaucoma; Ocular blood circulation; Randomized placebo controlled double masked trial

Indexed keywords

ANTHOCYANIN; ANTIGLAUCOMA AGENT; BLACK CURRANT ANTHOCYANIN DERIVATIVE; BLACK CURRANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLACK CURRANT; BLOOD FLOWMETRY; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EYE BLOOD FLOW; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; LASER SPECKLE FLOWGRAPHY; MALE; OPEN ANGLE GLAUCOMA; PERIMETRY; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VISUAL FIELD;

ADMINISTRATION, ORAL; AGED; ANTHOCYANINS; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAPSULES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, OPEN-ANGLE; HEART RATE; HUMANS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; OPTIC DISK; PLANT EXTRACTS; PROSPECTIVE STUDIES; REGIONAL BLOOD FLOW; RIBES; VISION DISORDERS; VISUAL FIELDS;

EID: 84863306720     PISSN: 00303755     EISSN: 14230267     Source Type: Journal    
DOI: 10.1159/000335961     Document Type: Article

References (47)

1. Shields MB: An overview of glaucoma; in Shields MB (ed): Textbook of Glaucoma, ed 4. Baltimore, Williams & Wilkins, 1988, pp 1-2.
2. Collaborative Normal-Tension Glaucoma Study Group: Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126: 487-497.
3. Collaborative Normal-Tension Glaucoma Study Group: The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998; 126: 498-505.
4. The AGIS Investigators: The Advanced Glaucoma Intervention Study (AIGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130: 429-440.
5. Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Gordon MO: The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701-713.
6. Kitazawa Y, Shirato S, Yamamoto T: Optic disc hemorrhage in low-tension glaucoma. Ophthalmology 1986; 93: 853-857.
7. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, Early Manifest Glaucoma Trial Group: Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial. Arch Ophthalmol 2003; 121: 48-56.
8. Barry CJ, Cooper RL, Eikelboom RH: Optic disc hemorrhages and vascular abnormalities in a glaucoma population. Aust NZ J Ophthalmol 1997; 25: 137-144.
9. Hirota A, Mishima HK, Kiuchi Y: Incidence of retinal vein occlusion at the glaucoma clinic of Hiroshima University. Ophthalmologica 1997; 211: 288-291.
10. Jonas JB, Naumann GO: Parapapillary retinal vessel diameter in normal and glaucoma eyes. II. Correlations. Invest Ophthalmol Vis Sci 1989; 30: 1604-1611.
11. Ogawa T, Ogawa A, So K: Target intraocular pressure and risk factors for progression of visual field loss in primary open-angle glaucoma. Nippon Ganka Gakkai Zasshi 2002; 106: 488-493.
12. Ohguro I, Ohguro H, Ohkuro H, Nakazawa M: Study of contribution of low level of plasma endothelin-1 concentration to pathogenesis of glaucomatous optic neuropathy. Hirosaki Med J 2006; 57: 59-64.
13. Ohguro I, Yamamoto Y, Takeuchi K, Ohguro H, Matsumoto M, Matsuhashi H, Nakazawa M: Relation between platelet aggregation rate and pathogenesis of glaucomatous optic neuropathy. J Eye 2005; 22: 669-672.
14. Renaud S, de Logeril M: Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526.
15. Nakaishi H, Matsumoto H, Tominaga S, Hirayama M: Effects of blackcurrant anthocyanoides intake on dark adaptation and VDT work-induced transient refractive alternation in healthy humans. Altern Med Rev 2000; 5: 553-562.
16. Matsumoto H, Kamm KE, Stull JT, Azuma H: Delphinidine-3-rutiniside relaxes the bovine ciliary smooth muscle through activation of ET B receptor and NO/cGMP pathway. Exp Eye Res 2005; 80: 313-322.
17. Haefliger IO, Flammer J, Bény JL, Lüscher TF: Endothelium-dependent vasoactive modulation in the ophthalmic circulation. Prog Retin Eye Res 2001; 20: 209-225.
18. Ohguro I, Ohguro H, Nakazawa M: Effects of anthocyanins in black currant on retinal blood flow circulation of patients with normal tension glaucoma. A pilot study. Hirosaki Med J 2007; 59: 23-32.
19. Anderson DR, Patella VM: Interpretation of a single field; in Anderson DR (ed): Automated Static Perimetry, ed 2. St Louis, Mosby, 1999, pp 121-190.
20. Koseki N, Araie M, Tomidokoro A, Nagahara M, Hasegawa T, Tamaki Y, Yamamoto S: A placebo-controlled 3-years study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure. Ophthalmology 2008; 115: 2049-2057.
21. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability. Ophthalmology 1994; 101: 1445-1455.
22. Ohguro I, Katai M, Tanaka S, Tsuruta M, Ohguro H: Blood flow in the optic nerve head following instillation of 1% dorzolamide in eyes with glaucoma. Jpn J Clin Ophthalmol 2010; 64: 921-926.
23. Logan JF, Rankin SJ, Jackson AJ: Retinal blood flow measurements and neuroretinal rim damage in glaucoma. Br J Ophthalmol 2004; 88: 1049-1054.
24. Yaoeda K, Shirakashi M, Fukushima A, Funaki S, Funaki H, Abe H, Tanabe N: Relationship between optic nerve microcirculation and visual field loss in glaucoma. Acta Ophthalmol Scand 2003; 81: 253-259.
25. Sato EA, Ohtake Y, Shinoda K, Mashima Y, Kimura I: Decreased blood flow at neuroretinal rim of optic nerve head corresponds with visual field deficit in eyes with normal tension glaucoma. Graefes Arch Clin Exp Ophthalmol 2006; 244: 795-801.
26. Hafez AS, Bizzarro RLG, Lesk MR: Evaluation of optic nerve head and peripapillary retinal blood flow in glaucoma patients, ocular hypertensive, and normal subjects. Am J Ophthalmol 2003; 136: 1022-1031.
27. Jonas JB, Gusek GC, Naumann GO: Optic disc, cup and neuroretinal rim size, configuration and correlation in normal eyes. Invest Ophthalmol Vis Sci 1988; 29: 1151-1158.
28. Harris A, Ishii Y, Chung HS, Jonescu- Cuypers CP, McCranor LJ, Kagemann L, Garzozi HJ: Blood flow per unit retinal nerve fiber tissue volume is lower in the human inferior retina. Br J Ophthalmol 2003; 87: 184-188.
29. Hart WM, Becker B: The onset and evolution of glaucomatous visual field defect. Ophthalmology 1982; 89: 268-279.
30. McGhie TK, Walton MC: The bioavailability and absorption of anthocyanins: towards a better understanding. Mol Nutr Food Res 2007; 51: 702-713.
31. Moller P, Loft S, Alfthan G, Freese R: Oxidative DNA damage in circulating mononuclear blood cells after ingestion of black currant juice or anthocyanins-rich drink. Mutat Res 2004; 551: 119-126.
32. Hirschberg Y, Shackelford A, Mascioli EA, Babayan VK, Bistrian BR, Blackburn GL: The response to endotoxin in guinea-pigs after intravenous blackcurrant seed oil. Lipid 1990; 25: 491-496.
33. Kamazawa Y, Kawaguchi K, Takimoto H: Immunomodulating effects of flavonoids on acute and chronic inflammatory responses caused by tumor necrosis factor alpha. Curr Pharma Des 2006; 12: 4271-4279.
34. Matsumoto H, Inaba H, Kishi M, Tominaga S, Hirayama M, Tsuda T: Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms. J Agric Food Chem 2001; 49: 1546-1551.
35. Matsumoto H, Nakamura Y, Iida H, Ito K, Ohguro H: Comparative assessment of distribution of black currant anthocyanins in rabbit and rat ocular tissues. Exp Eye Res 2006; 83: 348-356.
36. Matsumoto H, Nakamura Y, Tachibanaki S, Kawamura S, Hirayama M: Stimulatory effect of cyanidine 3-glycosides on the regeneration of rhodopsin. J Agric Food Chem 2003; 51: 3560-3563.
37. Iida H, Nakamura Y, Matsumoto H, Takeuchi Y, Harano S, Ishihara M, Katsumi O: Effect of black-currant extract on negative lens-induced ocular growth in chicks. Ophthalmic Res 2010; 44: 242-250.
38. MacCumber MW, D'Anna SA: Endothelin receptor-binding subtypes in the human retina and choroid. Arch Ophthalmol 1994; 112: 1231-1235.
39. Ripodas A, de Juan JA, Roldán-Pallarés M, Bernal R, Moya J, Chao M, López A, Fernández- Cruz A, Fernández-Durango R: Localization of endothelin-1 mRNA expression and immunoreactivity in the retina and optic nerve from human and porcine eye. Evidence for endothelin-1 expression in astrocytes. Brain Res 2001; 912: 137-143.
40. Oku H, Kida T, Sugiyama T, Hamada J, Sato B, Ikeda T: Possible involvement of endothelin- 1 and nitric oxide in the pathogenesis of proliferative diabetic retinopathy. Retina 2001; 21: 647-651.
41. Stangos AN, Petropoulos IK, Pournaras JA, Mendrinos E, Pournaras CJ: The vasodilatory effect of juxta-arteriolar microinjection of endothelin A receptor inhibitor in healthy and acute branch retinal vein occlusion mini pig retinas. Invest Ophthalmol Vis Sci 2010; 51: 2185-2190.
42. Kaiser HJ, Flammer J, Wenk M, Luschur T: Endothelin-1 plasma levels in normal-tension glaucoma. Abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol 1995; 233: 484-488.
43. Nicolela MT, Ferrier SN, Morrison CA, Archibald ML, Le Vatte TL, Wallace K, Chauhan BC, Le Blanc RP: Effects of cold-induced vasospasm in glaucoma: the role of endothelin- 1. Invest Ophthalmol Vis Sci 2003; 4: 2565-2572.
44. Venkataraman ST, Flanagan JG, Hudson C: Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma. Microcirculation 2010; 17: 568-581.
45. Good TJ, Kahook MY: The role of endothelin in the pathophysiology of glaucoma. Expert Opin Ther Targets 2010; 14: 647-654.
46. Cellini M, Possati GL, Profazio V, Sbrocca M, Caramazza N, Caramazza R: Color Doppler imaging and plasma levels of endothelin- 1 in low-tension glaucoma. Acta Ophthalmol Scand 1997; 224:S11-S13.
47. Kaiser HJ, Flammer J, Wenk M, Luschur T: Endothelin-1 plasma levels in normal-tension glaucoma. Abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol 1995; 233: 484-488.